C136H145F3N20O17S5 — CID 159237216
N-[4-[(2R)-4-(cyclopentylmethyl)-2-methylpiperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[4-[(2R)-4-(cyclopropylmethyl)-2-methylpiperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[4-[(2S)-4-[1-(3,5-difluorophenyl)ethyl]-2-ethylpiperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[4-[3-[(4-fluorophenyl)methyl]-3,8-diazabicyclo[3.2.1]octane-8-carbonyl]phenyl]quinoline-8-sulfonamide;propan-2-yl (3R)-3-methyl-4-[4-(quinolin-8-ylsulfonylamino)benzoyl]piperazine-1-carboxylate (PubChem CID 159237216) has the molecular formula C136H145F3N20O17S5 and a molecular weight of 2549.11 g/mol. Its IUPAC name is N-[4-[(2R)-4-(cyclopentylmethyl)-2-methylpiperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[4-[(2R)-4-(cyclopropylmethyl)-2-methylpiperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[4-[(2S)-4-[1-(3,5-difluorophenyl)ethyl]-2-ethylpiperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[4-[3-[(4-fluorophenyl)methyl]-3,8-diazabicyclo[3.2.1]octane-8-carbonyl]phenyl]quinoline-8-sulfonamide;propan-2-yl (3R)-3-methyl-4-[4-(quinolin-8-ylsulfonylamino)benzoyl]piperazine-1-carboxylate.
| Compound Name | N-[4-[(2R)-4-(cyclopentylmethyl)-2-methylpiperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[4-[(2R)-4-(cyclopropylmethyl)-2-methylpiperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[4-[(2S)-4-[1-(3,5-difluorophenyl)ethyl]-2-ethylpiperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[4-[3-[(4-fluorophenyl)methyl]-3,8-diazabicyclo[3.2.1]octane-8-carbonyl]phenyl]quinoline-8-sulfonamide;propan-2-yl (3R)-3-methyl-4-[4-(quinolin-8-ylsulfonylamino)benzoyl]piperazine-1-carboxylate |
|---|---|
| PubChem CID | 159237216 |
| Molecular Formula | C136H145F3N20O17S5 |
| Molecular Weight | 2549.11 g/mol |
| Exact Mass | 2546.97 |
| IUPAC Name | N-[4-[(2R)-4-(cyclopentylmethyl)-2-methylpiperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[4-[(2R)-4-(cyclopropylmethyl)-2-methylpiperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[4-[(2S)-4-[1-(3,5-difluorophenyl)ethyl]-2-ethylpiperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[4-[3-[(4-fluorophenyl)methyl]-3,8-diazabicyclo[3.2.1]octane-8-carbonyl]phenyl]quinoline-8-sulfonamide;propan-2-yl (3R)-3-methyl-4-[4-(quinolin-8-ylsulfonylamino)benzoyl]piperazine-1-carboxylate |
| SMILES | CC(C)OC(=O)N1CCN(C(=O)c2ccc(NS(=O)(=O)c3cccc4cccnc34)cc2)[C@H](C)C1.CC[C@H]1CN(C(C)c2cc(F)cc(F)c2)CCN1C(=O)c1ccc(NS(=O)(=O)c2cccc3cccnc23)cc1.C[C@@H]1CN(CC2CC2)CCN1C(=O)c1ccc(NS(=O)(=O)c2cccc3cccnc23)cc1.C[C@@H]1CN(CC2CCCC2)CCN1C(=O)c1ccc(NS(=O)(=O)c2cccc3cccnc23)cc1.O=C(c1ccc(NS(=O)(=O)c2cccc3cccnc23)cc1)N1C2CCC1CN(Cc1ccc(F)cc1)C2 |
| InChI | InChI=1S/C30H30F2N4O3S.C29H27FN4O3S.C27H32N4O3S.C25H28N4O5S.C25H28N4O3S/c1-3-27-19-35(20(2)23-16-24(31)18-25(32)17-23)14-15-36(27)30(37)22-9-11-26(12-10-22)34-40(38,39)28-8-4-6-21-7-5-13-33-29(21)28;30-23-10-6-20(7-11-23)17-33-18-25-14-15-26(19-33)34(25)29(35)22-8-12-24(13-9-22)32-38(36,37)27-5-1-3-21-4-2-16-31-28(21)27;1-20-18-30(19-21-6-2-3-7-21)16-17-31(20)27(32)23-11-13-24(14-12-23)29-35(33,34)25-10-4-8-22-9-5-15-28-26(22)25;1-17(2)34-25(31)28-14-15-29(18(3)16-28)24(30)20-9-11-21(12-10-20)27-35(32,33)22-8-4-6-19-7-5-13-26-23(19)22;1-18-16-28(17-19-7-8-19)14-15-29(18)25(30)21-9-11-22(12-10-21)27-33(31,32)23-6-2-4-20-5-3-13-26-24(20)23/h4-13,16-18,20,27,34H,3,14-15,19H2,1-2H3;1-13,16,25-26,32H,14-15,17-19H2;4-5,8-15,20-21,29H,2-3,6-7,16-19H2,1H3;4-13,17-18,27H,14-16H2,1-3H3;2-6,9-13,18-19,27H,7-8,14-17H2,1H3/t20?,27-;;20-;2*18-/m0.111/s1 |
| InChIKey | KTPZSJPRDMTYMJ-GMBXZGSESA-N |
| XLogP | 21.97 |
| TPSA | 439.35 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 181 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2549.11 |
| LogP ≤ 5 | 21.97 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 26 |